{"id":"W4407932301","doi":"10.1021/acs.oprd.4c00528","title":"Development of a Scalable Manufacturing Process for AB-343 Drug Substance: A Potential Candidate for the Treatment of Coronavirus Infections","year":2025,"lang":"en","type":"article","venue":"Organic Process Research & Development","topic":"Computational Drug Discovery Methods","field":"Computer Science","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"Arbutus Biopharma (Canada)","funders":"","keywords":"Drug; Coronavirus disease 2019 (COVID-19); Coronavirus; Process development; Drug development; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); Drug candidate; Virology; Manufacturing process; 2019-20 coronavirus outbreak; Medicine; Pharmacology; Nanotechnology; Biochemical engineering; Materials science; Process engineering; Engineering; Infectious disease (medical specialty); Internal medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003864394,0.0004509447,0.0003036492,0.0002354932,0.0002310337,0.0003443855,0.0003445518,0.0003846732,0.001277182],"category_scores_gemma":[0.0002817919,0.0002429394,0.0004412233,0.0001689483,0.0002104117,0.0003465037,0.000368168,0.0008625552,0.000861336],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002561656,"about_ca_system_score_gemma":0.0007167653,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004056101,"about_ca_topic_score_gemma":0.0007016914,"domain_scores_codex":[0.9998181,0.0000213902,0.00001349923,0.00003649905,0.00008527163,0.0000252925],"domain_scores_gemma":[0.9999018,0.00001652789,0.00002958151,0.00001456833,0.00001958426,0.00001804343],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.00002787022,0.00004706297,0.00005078491,0.00006447812,0.000005724477,0.00007670201,0.00001452367,0.0005340967,0.9939943,0.0003941718,0.0001042912,0.004686126],"study_design_scores_gemma":[0.00004791567,0.000569429,0.0003967818,0.00001141879,0.00001693345,0.0002247512,0.00001369999,0.005028484,0.9870308,0.0001781052,0.006470522,0.00001124486],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.6242824,0.00302566,0.3590082,0.0007181201,0.0002579789,0.001463682,0.001287396,0.001572054,0.008384329],"genre_scores_gemma":[0.7126791,0.00244543,0.2793501,0.0001501461,0.00005511491,0.0006112874,0.0009881742,0.0001353875,0.003585199],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001277182,"threshold_uncertainty_score":0.00427258,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06034771826173993,"score_gpt":0.4090725288869526,"score_spread":0.3487248106252127,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}